Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Feb 2, 2022

Accession no.
0001209191-22-006172
Filed
Feb 2, 2022, 7:18 AM ET
Trade date
Feb 1, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market purchases total $455.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 1, 2022Common StockPPurchaseAcquired+1,200$3.00+$3,594193,522,894Indirect
Feb 1, 2022Common StockPPurchaseAcquired+18,800$3.00+$56,400193,541,694Indirect
Feb 1, 2022Common StockPPurchaseAcquired+12,000$3.02+$36,240193,553,694Indirect
Feb 1, 2022Common StockPPurchaseAcquired+19,200$3.03+$58,176193,572,894Indirect
Feb 1, 2022Common StockPPurchaseAcquired+6,300$3.03+$19,104.75193,579,194Indirect
Feb 1, 2022Common StockPPurchaseAcquired+20,600$3.04+$62,521193,599,794Indirect
Feb 1, 2022Common StockPPurchaseAcquired+9,900$3.04+$30,096193,609,694Indirect
Feb 1, 2022Common StockPPurchaseAcquired+44,500$3.05+$135,502.5193,654,194Indirect
Feb 1, 2022Common StockPPurchaseAcquired+17,500$3.05+$53,375193,671,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)